• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Zenyaku Kogyo gets Japanese approval for anti-CD20 mAb, Rituxan

    PHARMABIZ

    Zenyaku Kogyo receives Japanese nod for Rituxan in systemic sclerosis

    PHARMABIZ

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.